Drugs / Human rotavirus liquid vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00345956 | Sep 2006 → Mar 2007 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human rotavirus liquid vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00345956 ↗ |
| Known as | HRV liquid vaccine | “GSK Biologicals' HRV liquid vaccine” NCT00345956 ↗ |
| Modality | Vaccine | “Oral Live Attenuated Human Rotavirus (HRV) Liquid Vaccine” NCT00345956 ↗ |
| Route | Oral | “Oral Live Attenuated Human Rotavirus (HRV) Liquid Vaccine” NCT00345956 ↗ |